Nagore Eduardo, Moro Ruggero
Department of Dermatology, Instituto Valenciano de Oncología (IVO), Valencia, Spain -
Graduate School, Valencia Catholic University Saint Vincent Martyr, Valencia, Spain.
Ital J Dermatol Venerol. 2021 Jun;156(3):331-343. doi: 10.23736/S2784-8671.20.06776-0. Epub 2020 Dec 14.
Surgery is the main treatment for cutaneous melanoma including the primary melanoma as well as lymph node metastases. The recommended margins have changed over time. Similarly, indications for sentinel lymph node biopsy and complete lymph node dissection are constantly evolving if knowledge on the biological behavior of melanomas increases. The current guidelines and the most relevant literature were reviewed to provide an update on the existing recommendations for surgical management of melanoma. Wide excision margins are evidenced-based but not for all situations. Melanoma in situ requires 0.5-1 cm with increasing evidence for 1 cm particularly those presenting on the head-and-neck in the setting of chronic sun damage. Invasive melanomas need 1-2 cm margins, 2 cm for tumors thicker than 2 mm and some large tumors with >1-2 mm thickness and with a lentiginous growth pattern. Lentigo maligna, subungual melanoma, and acral lentiginous melanoma require surgical techniques with complete circumferential peripheral margin assessment. Sentinel lymph node biopsy provides relevant information for melanoma staging. Therefore, it is consistently recommended for melanomas >1-4 mm and highly recommended for melanomas >4 mm, >0.8-1.0 mm or ≤0.8 mm with additional risk factors. Complete lymph node dissection has high morbidity and no impact on survival and is restricted to regional control for clinically detected metastasis. Although the trend is to reduce progressively the recommended surgical margins, further evidence is needed to clarify its role in patients' survival. Sentinel lymph node biopsy is important for establishing a prognosis especially upon considering adjuvant therapy; complete lymph node dissection is only relevant for regional disease control.
手术是皮肤黑色素瘤的主要治疗方法,包括原发性黑色素瘤以及淋巴结转移瘤。推荐的切缘范围随时间有所变化。同样地,随着对黑色素瘤生物学行为的认识增加,前哨淋巴结活检和完整淋巴结清扫的指征也在不断演变。我们回顾了当前的指南和最相关的文献,以更新黑色素瘤手术管理的现有建议。广泛切除切缘是基于证据的,但并非适用于所有情况。原位黑色素瘤需要0.5 - 1厘米的切缘,越来越多的证据支持1厘米的切缘,特别是那些在慢性阳光损伤背景下出现在头颈部的原位黑色素瘤。侵袭性黑色素瘤需要1 - 2厘米的切缘,肿瘤厚度超过2毫米以及一些厚度>1 - 2毫米且具有雀斑样生长模式的大肿瘤需要2厘米的切缘。恶性雀斑样痣、甲下黑色素瘤和肢端雀斑样痣黑色素瘤需要采用能够完整评估外周切缘的手术技术。前哨淋巴结活检为黑色素瘤分期提供相关信息。因此,对于厚度>1 - 4毫米的黑色素瘤一直推荐进行前哨淋巴结活检,对于厚度>4毫米、>0.8 - 1.0毫米或≤0.8毫米且有其他危险因素的黑色素瘤则强烈推荐进行前哨淋巴结活检。完整淋巴结清扫具有较高的发病率且对生存率无影响,仅限于对临床检测到的转移灶进行区域控制。尽管趋势是逐渐缩小推荐的手术切缘范围,但仍需要进一步的证据来阐明其在患者生存中的作用。前哨淋巴结活检对于确立预后尤其是在考虑辅助治疗时非常重要;完整淋巴结清扫仅与区域疾病控制相关。